Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Yang

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Hematological Oncology|August 4, 2021
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysisChristopher R D'Angelo, Walter Hanel, Yi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2015
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.
BMC Infectious Diseases|August 1, 2008
Early indicators of exposure to biological threat agents using host gene profiles in peripheral blood mononuclear cellsRina Das, Rasha Hammamieh, Roger Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 31, 2025
Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery diseaseSanjay Divakaran, Hendrik J Harms, Matthew Robertson, et al.
Blood|October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformationXiaona You, Fabao Liu, Moritz Binder, et al.
Annals of Neurology|January 7, 2015
Pin1 promotes neuronal death in stroke by stabilizing Notch intracellular domainSang-Ha Baik, Mitchell Fane, Joon Hyung Park, et al.
BMC Cancer|February 27, 2025
A multi-centre, participant-blinded, randomized, 3-year study to compare the efficacy of Virtual Surgical Planning (VSP) to Freehand Surgery (FHS) on bony union and quality of life outcomes for mandibular reconstruction with fibular and scapular free flaps: study protocol for a randomized phase II/III trialKhanh Linh Tran, Sena Turkdogan, Anat Bahat Dinur, et al.
Elife|September 28, 2023
Multiomics analyses reveal dynamic bioenergetic pathways and functional remodeling of the heart during intermittent fastingThiruma V Arumugam, Asfa Alli-Shaik, Elisa A Liehn, et al.
Nature Communications|November 28, 2025
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trialAdrienne G Waks, Jingxin Fu, Xiangying Chu, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Hematological Oncology|August 4, 2021
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysisChristopher R D'Angelo, Walter Hanel, Yi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2015
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.
BMC Infectious Diseases|August 1, 2008
Early indicators of exposure to biological threat agents using host gene profiles in peripheral blood mononuclear cellsRina Das, Rasha Hammamieh, Roger Neill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 31, 2025
Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery diseaseSanjay Divakaran, Hendrik J Harms, Matthew Robertson, et al.
Blood|October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformationXiaona You, Fabao Liu, Moritz Binder, et al.
Annals of Neurology|January 7, 2015
Pin1 promotes neuronal death in stroke by stabilizing Notch intracellular domainSang-Ha Baik, Mitchell Fane, Joon Hyung Park, et al.
BMC Cancer|February 27, 2025
A multi-centre, participant-blinded, randomized, 3-year study to compare the efficacy of Virtual Surgical Planning (VSP) to Freehand Surgery (FHS) on bony union and quality of life outcomes for mandibular reconstruction with fibular and scapular free flaps: study protocol for a randomized phase II/III trialKhanh Linh Tran, Sena Turkdogan, Anat Bahat Dinur, et al.
Elife|September 28, 2023
Multiomics analyses reveal dynamic bioenergetic pathways and functional remodeling of the heart during intermittent fastingThiruma V Arumugam, Asfa Alli-Shaik, Elisa A Liehn, et al.
Nature Communications|November 28, 2025
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trialAdrienne G Waks, Jingxin Fu, Xiangying Chu, et al.
Pageof 19